Absci Corporation (ABSI)
(Delayed Data from NSDQ)
$4.58 USD
+0.13 (2.81%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.57 -0.01 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Price, Consensus and EPS Surprise
ABSI 4.58 +0.13(2.81%)
Will ABSI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ABSI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABSI
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?
ABSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
Is Absci Corporation (ABSI) Outperforming Other Medical Stocks This Year?
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
Other News for ABSI
Moderna and OpenAI in pact to fast-track drug development
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week
Video: Tuesday's ETF Movers: ARKG, PICK
All 7 AI Category Portfolios Continued To Decline This Week
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024